Teva, Drug Manufacturer Antitrust Cases Sent Back to Connecticut

Several antitrust lawsuits against top drugmakers will be sent back to Connecticut federal court, a judicial panel said Wednesday, denying about 40 defendants’ bid to pull the cases into multidistrict litigation in Pennsylvania.

Acknowledging that the move could “temporarily disrupt proceedings,” the US Judicial Panel on Multidistrict Litigation pointed to an amendment to a law that took effect in 2022, which allowed states to avoid consolidating antitrust cases when they haven’t waived their rights.

The panel was also unconvinced by the drugmakers’ arguments the federal law should be interpreted and applied differently because the multidistrict litigation was in the Third ...